Track the DIASORIN share price and the full management transaction log of the company, a listed issuer based in Italy. Shares are listed on IT IT, under the oversight of Consob. Operating in the Health Care sector, DIASORIN has published 0 public disclosures. Market capitalisation: €3.3bn. Every trade is free.
Analysts rate DIASORIN Hold (neutral), based on 14 analysts. Average price target: €70.16.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
DIASORIN is a company specializing in in vitro diagnostics, providing solutions for testing infectious diseases and other medical conditions. It is listed on the XMIL stock market.